Atrial natriuretic peptide elevation in congestive heart failure in the human.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Science

• Publication date

  1986-03-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1126/SCIENCE.2935937PMID 2935937
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renal response to atrial natriuretic factor in conscious dogs with caval constriction.

  1985cited by this paper
• Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure.

  1985cited by this paper
• Cardiac atria of BIO 14.6 hamsters are deficient in natriuretic factor.

  1984cited by this paper
• Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.

  1984cited by this paper
• Rat atrial natriuretic factor: complete amino acid sequence and disulfide linkage essential for biological activity.

  1984cited by this paper
• Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide

  1984cited by this paper
• Effects of synthetic atrial natriuretic factor on renal function and renin release.

  1984cited by this paper
• Purification and sequence analysis of bioactive atrial peptides (atriopeptins).

  1984cited by this paper
• The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties.

  1983cited by this paper
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

  1981cited by this paper

• Neprilysin 2 catalyses the degradation of natriuretic peptides despite sacubitrilat Inhibition

  2025cites this paper
• Novel PDE9 inhibitors, KR39526 and KR39582, attenuate cardiac hypertrophy and fibrosis induced by pressure overload.

  2025cites this paper
• Advances in Cardiovascular Pharmacotherapy. VI. Sacubitril-Valsartan, An Angiotensin Receptor-Neprilysin Inhibitor.

  2025cites this paper
• NT-pro Brain Natriuretic Peptide in Infants with Single Ventricle Heart Disease in the CHAMP® Multi-site Registry.

  2025cites this paper
• Long-lasting heart-failure treatment could be a game-changer

  2024cites this paper
• Cardiac natriuretic peptides.

  2024cites this paper
• The Impact of Natriuretic Peptides on Heart Development, Homeostasis, and Disease

  2024cites this paper
• Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria

  2023cites this paper
• SEX-BASED DIFFERENCES IN METABOLIC PROTECTION BY THE ANP GENETIC VARIANT rs5068 IN THE GENERAL POPULATION.

  2023cites this paper
• EVIDENCE FOR ANGIOTENSIN II AS A NATURALLY EXISTING SUPPRESSOR FOR THE NATRIURETIC PEPTIDE SYSTEM

  2023influential citation
• BNP and NT-proBNP Thresholds for the Assessment of Prognosis in Patients Without Heart Failure

  2023cites this paper
• Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation

  2023influential citation
• Biochemistry of the Endocrine Heart

  2022cites this paper
• Atrial Natriuretic Peptide Associated with Cardiovascular Diseases Inhibits Amyloid-β Aggregation via Cross-Seeding.

  2022cites this paper
• Natriuretic peptide pathways in heart failure: further therapeutic possibilities

  2022cites this paper
• Mosaic Attenuation Pattern: A Guide to Analysis with HRCT.

  2022cites this paper
• Biomarker Development in Cardiology: Reviewing the Past to Inform the Future

  2022cites this paper
• Edema formation in congestive heart failure and the underlying mechanisms

  2022cites this paper
• Incidence of Preclinical Heart Failure in a Community Population

  2022cites this paper
• The Protective Role of the Long Pentraxin PTX3 in Spontaneously Hypertensive Rats with Heart Failure

  2021cites this paper
• First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension

  2021cites this paper
• Atrial Natriuretic Peptide31–67: A Novel Therapeutic Factor for Cardiovascular Diseases

  2021cites this paper
• Angiotensin (1-12) in Humans With Normal Blood Pressure and Primary Hypertension.

  2021cites this paper
• Cardiovascular Safety Assessment in Cancer Drug Development

  2021cites this paper
• Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis

  2021cites this paper
• Atrial Natriuretic Peptides, Right Atrial Infarction and Prognosis of Patients with Myocardial Infarction—A Single-Center Study

  2021cites this paper
• Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators

  2021cites this paper
• The Utility of Circulating and Imaging Biomarkers Alone and in Combination in Heart Failure

  2021cites this paper
• Cardiac natriuretic peptide deficiency sensitizes the heart to stress induced ventricular arrhythmias via impaired CREB signaling.

  2021cites this paper
• Cardiac Natriuretic Peptide Profiles in Chronic Hypertension by Single or Sequentially Combined Renovascular and DOCA-Salt Treatments

  2021cites this paper
• Sodium‐glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review

  2021cites this paper
• Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure.

  2021cites this paper
• Natriuretic peptides as the basis of peptide drug discovery for cardiovascular diseases.

  2020cites this paper
• Paeonol Reverses Adriamycin Induced Cardiac Pathological Remodeling through Notch1 Signaling Reactivation in H9c2 Cells and Adult Zebrafish Heart.

  2020cites this paper
• Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment

  2020cites this paper
• Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases

  2020cites this paper
• Neprilysin: A Potential Therapeutic Target of Arterial Hypertension?

  2020cites this paper
• Chamber-specific regulation of atrial natriuretic peptide secretion in cardiac hypertrophy: atrial wall dynamics in the ANP secretion

  2020cites this paper
• Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure

  2020cites this paper
• Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy

  2020cites this paper
• Deficiency of Cardiac Natriuretic Peptide Signaling Promotes Peripartum Cardiomyopathy-Like Remodeling in the Mouse Heart

  2020cites this paper
• Natriuretic Peptides in Heart Failure: Pathophysiologic and Therapeutic Implications

  2020cites this paper
• Long-Term Blood Pressure Lowering and cGMP Activating Actions of the Novel ANP Analogue MANP.

  2020cites this paper
• Multiplicity of Nitric Oxide and Natriuretic Peptide Signalling in Heart Failure.

  2020cites this paper
• Natriuretic Peptides, Inflammation, and Sounding the Alarm.

  2020cites this paper
• Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction

  2020cites this paper
• cGMP Signaling in Cardiovascular Diseases: Linking Genotype and Phenotype.

  2020cites this paper
• Heart Hormones

  2020cites this paper
• Cardiovascular Changes in Children with Acute Lower Respiratory Tract Infection

  2019cites this paper
• Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular Disease

  2019cites this paper
• Endurance Training in the Spontaneously Hypertensive Rat

  2019cites this paper
• Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.

  2019cites this paper
• Renin Activity in Heart Failure with Reduced Systolic Function—New Insights

  2019cites this paper
• Natriuretic peptides as therapeutic agents

  2019influential citation
• Procholecystokinin expression and processing in cardiac myocytes.

  2019cites this paper
• The historical evolution of knowledge of the involvement of neurohormonal systems in the pathophysiology and treatment of heart failure

  2019cites this paper
• Are Some Patients With Acute Heart Failure ANP-Deficient?

  2019cites this paper
• Plasma proatrial natriuretic peptide associates with lipid oxidation during exercise and cardiorespiratory fitness in healthy young adults.

  2019cites this paper
• Diagnostic methods for the canine idiopathic dilated cardiomyopathy: A narrative evidence-based rapid review.

  2019cites this paper
• Evaluation of Lignan Compound Content and Bioactivity of Raw Omija and Sugared Omija in Serum of Sprague Dawley Rat

  2019cites this paper
• The historical evolution of knowledge of the involvement of neurohormonal systems in the pathophysiology and treatment of heart failure.

  2019cites this paper
• Doxorubicin-Induced Cardiomyopathy in Children.

  2019cites this paper
• Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP.

  2019cites this paper
• Successful full-term delivery in a patient with maintenance hemodialysis using natriuretic peptides as volume markers without X-ray examination: a case report and literature review

  2019cites this paper
• University of Groningen Atrial remodeling due to atrial tachycardia and heart failure Schoonderwoerd,

  2018cites this paper
• Studies on the Genetics of Heart Failure

  2018cites this paper
• Assoziation zwischen Angstsymptomen und der Serum-Konzentration von Endothelin-1 bei diastolischer Dysfunktion

  2018cites this paper
• Neurohormonal Axis and Natriuretic Peptides in Heart Failure

  2018cites this paper
• Guanylyl Cyclase A in Both Renal Proximal Tubular and Vascular Endothelial Cells Protects the Kidney against Acute Injury in Rodent Experimental Endotoxemia Models

  2018cites this paper
• CLINICAL VALUE OF BLOOD BIOMARKERS IN PATIENTS WITH CHRONIC HEART FAILURE

  2018cites this paper
• A concise discussion of the regulatory role of cGMP kinase I in cardiac physiology and pathology

  2018cites this paper
• Cardiomyokines from the heart

  2018cites this paper
• Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study

  2018cites this paper
• Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population

  2018cites this paper
• Association of B-Type Natriureteric Peptide Levels With Estimated Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease And Relevant Echocardiographic Changes

  2018cites this paper
• NEW BIOMARKERS OF HEART FAILURE : DIAGNOSTIC AND PROGNOSTIC VALUE OF NT-proBNP AND INTERLEUKIN RECEPTOR FAMILY MEMBER ST 2

  2018cites this paper
• Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.

  2018cites this paper
• КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ ОПРЕДЕЛЕНИЯ БИОМАРКЕРОВ КРОВИ У БОЛЬНЫХ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ

  2018cites this paper
• Effect of the renal natriuretic peptide, ularitide, alone or combined with Vasopeptidase inhibitor, Omapatrilat, on experimental volume overload-induced congestive heart failure in rats (Ularitide/Omapatrilat in Congestive Heart Failure)

  2017cites this paper
• Breakthrough in Heart Failure therapy: LCZ696 combining ACE-Neprilysin inhibition

  2017cites this paper
• Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug

  2017cites this paper
• Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation

  2017cites this paper
• Heart failure and kidney Crucial & Common pathophysiological pathways

  2017cites this paper
• Three molecular forms of atrial natriuretic peptides: quantitative analysis and biological characterization

  2017cites this paper
• Heart Failure with Normal Left Ventricular Ejection Fraction (HFNEF)

  2017cites this paper
• Cardiomyokines from the heart

  2017cites this paper
• Cardiac Natriuretic Peptides

  2017cites this paper
• A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination.

  2017cites this paper
• STAT3 balances myocyte hypertrophy vis-à-vis autophagy in response to Angiotensin II by modulating the AMPKα/mTOR axis

  2017cites this paper
• Targeting multidrug resistance proteins and C-type natriuretic peptide to optimise cyclic GMP signalling in cardiovascular disease

  2016cites this paper
• Cardiovascular-Active Venom Toxins: An Overview.

  2016cites this paper
• ardiorenal fibrosis and dysfunction in aging : Imbalance in mediators nd regulators of collagen

  2016cites this paper
• Effects of inhibitory G protein upon muscarinic and ß-adrenergic signaling in the failing heart

  2016cites this paper
• Cardiorenal Signaling Pathways in Heart Failure: Good and Bad News

  2016cites this paper
• Cardiac natriuretic peptides in plasma: from prediction to precision medicine.

  2016cites this paper
• The Endocrine Heart

  2016cites this paper
• A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.

  2016cites this paper
• Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure

  2016cites this paper
• Low-dose dasatinib rescues cardiac function in Noonan syndrome.

  2016cites this paper
• Serum proatrial natriuretic peptide does not increase with higher systolic blood pressure in obese men

  2016cites this paper